Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Durable Equipment Cuts Will Deepen In Next Round Of Competitive Bidding

This article was originally published in The Gray Sheet

Executive Summary

Starting July 1, Medicare plans to pay 45 percent less than current fee-schedule rates for eight categories of DMEPOS in 91 cities, and 72 percent less nationwide for diabetes products.

You may also be interested in...



Medicare Competitive Bidding Makes Big Impression On U.S. Diabetes Device Earnings

Johnson & Johnson and Abbott Laboratories each reported massive double-digit revenue drops for their U.S. diabetes product divisions in earnings reports this week, citing the impact of the national Medicare competitive bidding program for diabetes supplies. Roche had better-looking results for the most recent quarter, but also has taken a big hit from massive reimbursement cuts resulting from nationwide bidding.

Medicare Competitive Bidding Makes Big Impression On U.S. Diabetes Device Earnings

Johnson & Johnson and Abbott Laboratories each reported massive double-digit revenue drops for their U.S. diabetes product divisions in earnings reports this week, citing the impact of the national Medicare competitive bidding program for diabetes supplies. Roche had better-looking results for the most recent quarter, but also has taken a big hit from massive reimbursement cuts resulting from nationwide bidding.

DME Suppliers Down 27 Percent In Competitive Bidding Areas In 2012 – GAO

Durable medical equipment suppliers dropped by 27 percent in Medicare competitive bidding areas while only 5 percent of DME suppliers were lost in comparable, non-bidding areas. But the second year of the program’s round 1 rebid in 2012 saved Medicare $400 million, according to a newly-released Government Accountability Office report.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT032667

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel